An in-depth look to HANALL BIOPHARMA CO.,LTD operating, investing, and financing activities

009420 free cash flow for Q3 24 is -3.07 B KRW. For 2023, 009420 free cash flow was 27.23 B KRW and operating cash flow was 29.64 B KRW.